During the past decade, Klinika Infekcních nemocí conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinika Infekcních nemocí" #1 collaborator was "Novartis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Klinika Infekcních nemocí" are "Chronic Hepatitis C" (1 trials) and "Hepatitis C, Chronic" (1 trials). Many other conditions were trialed in "Klinika Infekcních nemocí" in a lesser frequency.

Most popular intervention types in "Klinika Infekcních nemocí" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ribavirin" (2 trials), "Albuferon" (1 trials), "PEG-IFNalfa2a" (1 trials), "albumin interferon alfa-2b" (1 trials) and "peginterferon alfa-2a" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinika Infekcních nemocí" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Klinika Infekcních nemocí". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Klinika Infekcních nemocí, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinika Infekcních nemocí, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".